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hin-film bioceramic coatings are potential alternatives to overcome the limitations provided by other commercially available coating techniques
like PSHA, where variable bioceramic dissolution added to a metalloceramic weak link are process- inherent. The purpose of this investigation was
to determine the overall and site specific (to 0.5 mm from implant surface) levels of osseoactivity around a thin-film (IBAD processed) coated
titanium alloy implant versus a non surface modified (sand-blasted/acid etched) titanium alloy implant in a canine model. The surgical model
comprised the proximal tibiae epiphyses with four implants placed in each limb remaining for 2 and 4 weeks in-vivo. 10 mg/Kg oxytetracycline was
administered 48 hours prior to euthanization. The limbs were retrieved by sharp dissection, reduced to blocks, and subsequently nondecalcified
processed for fluorescent microscopy. Micrographs (20x mag) were acquired around the implant perimeter and merged for overall biological response
evaluations, and four micrographs (40x mag. subdivided in rectangles) were acquired along one of the implant sides for tetracycline labeled area
fraction quantification. The results showed biocompatible and osseoconductive properties for the thin-film coated and uncoated titanium alloy
implants. Tetracycline labeled area fraction analyses showed that the thin-film coated implants presented significantly higher overall and site specific
osseoactivity levels at 2 and 4 weeks. The site specific osseoactivity values were significantly higher compared to overall values for control and thin-
film coated implants at both times in-vivo. According to the results obtained in this study, thin-film coated implants enhanced biological response at
the early implantation times evaluated.
Uniterms: Dental implants; Thin-film coatings; Osseointegration; Tetracycline labeling; Bioceramic; Histomorphometry measurements; Dogs.
   ecobrimentos biocerâmicos de baixa espessura são potenciais alternativas para compensar as limitações de outros recobrimentos biocerâmicos
disponíveis comercialmente como o plasma spray de hidroxiapatita, onde a dissolução desigual  e a presença de uma fraca interface metal-cerâmica são
problemas inerentes ao seu processamento. O propósito desta investigação foi determinar os níveis de atividade óssea total e específica a uma área (0.5
mm da superfície do implante) ao redor de um implante de liga de titânio (superficie jateada seguida de ataque ácido) recoberto com um filme biocerâmico
de baixa espessura processado através de deposição auxiliada por feixe iônico, contra um implante de liga de titânio sem recobrimento biocerâmico em
cães. O modelo cirúrgico utilizou a epífise proximal da tibia, com quatro implantes colocados em cada uma, onde permaneceram por um período de 2 e
4 semanas. Oxitetraciclina (10 mg/Kg) foi administrada 48 horas antes dos animais serem sacrificados. As tíbias foram dissecadas, reduzidas a blocos,  e
processadas para análise em microscópio ótico. Microfotografias com aumento de 20x foram obtidas da região perimetral do implante e foram alinhadas
para análise da resposta biológica total. Subsequentemente, quatro micro-fotografias com aumento de 40x, sub- divididas em retângulos, foram obtidas de
um dos lados do implante para quantificação da área marcada por tetraciclina. Os resultados mostraram biocompatibilidade e osseocondutividade dos
implantes de liga de titânio com ou sem filme biocerâmico de baixa espessura. Análise da área marcada por tetraciclina mostrou que os implantes com
recobrimento apresentaram uma maior atividade óssea total e específica ao redor do implante em 2 e 4 semanas. Os valores de atividade óssea específica
à área adjacente à superfície do implante foram significantemente maiores comparados aos valores obtidos em regiões afastadas dos implantes com ou sem
recobrimento biocerâmico. De acordo com os resultados obtidos neste estudo, concluímos que os implantes com recobrimento biocerâmico de baixa
espessura aumentaram a resposta biológica após 2 e 4 semanas de tempo de implantação.
Unitermos: Implantes dentários; Recobrimentos de baixa espessura; Osseointegração; Tetraciclina; Análise histomorfométrica; Biocerâmica; Cães.
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INTRODUCTION AND BACKGROUND
The success of dental implants requires their anchorage
in bone in order to withstand functional loading. This idea is
accepted since both archaeology and histology records
provide evidence of dental implants endosseous integration5.
Significant evolution on both surgical and restorative
aspects of dental implantology have occurred since the term
osseointegration2 (direct bone apposition at the surface of
either titanium or titanium alloys) was defined by a Swedish
research group in the late seventies1. This term has been
constantly redefined and by no means represents the
complexity of the phenomena occurring at the bone-biomaterial
interface.
While predictable outcomes have been reported since
endosseous’ implants early days following the classical two-
stage technique protocol, a desire for treatment time decrease
while maintaining success rates reported above 90%2-3  has
been demonstrated by practitioners and patients.
Many attempts have been made on the manufacturing
processes of dental implants in order to improve biological
response of the host to materials. For this purpose, surface
engineering methods have been under constant investigation,
once it was known that some surface modifications notably
changed the in-vivo performance of biomaterials7,21,28.
Several engineering processes have been used to modify
the surface of dental implants in an attempt to increase bone
wound healing kinetics and decrease treatment time frames20,22.
Among popular surface modifications are the incorporation
of calcium- and phosphate-based bioceramics to the surface
of commercially pure titanium and titanium alloys in the form
of apatites29 or phases of other stoichiometry (calcium to
phosphate ratios)20. The elemental components of these
phases are found in the composition of natural bone, leading
to a rationale for employment of biomaterials synthetically
manufactured to resemble these compositions as implant
materials20,22,29.
Plasma Spraying of Hydroxyapatite (PSHA) is by far the
most commonly used coating technique for bioceramic
incorporation on dental implants to the present day due to its
processing versatility and simplicity, where virtually all implant
bulk designs may receive a continuous coating layer on its
surface19-20,22. Its manufacturing process has been thoroughly
described19, and PSHA coatings have been shown to elicit
earlier biological responses around implants8-9,11,17-18.
Limitations concerning PSHA processed bioceramic coatings
are the variable dissolution rates due to the inherent
multiphase microstructure obtained through this process15,19-
20,25,30, added to the presence of a metalloceramic weak link
between the bulk metallic substrate and bioceramic coating,
which relies on mechanical interlocking for its integrity and
maintenance20,22.
In an attempt to overcome the limitations of the PSHA
process while still benefiting from the increased
osseoconductive properties provided by bioceramic coatings,
thin-films of highly controlled microstructures and thicknesses
have been engineered on the surface of dental implants. These
thin-films may be deposited by a variety of techniques
including sol-gel, Pulsed Laser Deposition (PLD), Ion Beam
Assisted Deposition (IBAD), and others20,22. A potential
advantage of thin-film processes is the tailored bioceramic
dissolution as a function of time in-vivo, providing implant
surface exposure as implantation time elapses, enabling direct
bone contact to the implant surface. This direct bone contact
to the metallic substrate favors the bone-biomaterial interface
mechanical competence by avoiding metalloceramic weak links
between the metallic substrate and coating, as found on PSHA
coated implants20,22.
 Due to the dynamic modeling/remodeling nature of bone
during wound healing and homeostasis, there is a need for
specific labeling tools for hard tissue kinetics’
histomorphometric assessment. A bone tissue marker is
defined as any identifiable feature, naturally occurring or
artificially induced, which permits the location of a given bone
surface in anatomical space at a known moment in time26. The
use of tetracycline (TC) as a tissue marker was introduced23-
24, reviewed4,13 and has been recently applied6.16 due to its
fluorescent properties, which allow for determination of
osteoblastic activity (osseoactivity) in nondecalcified
specimens. TC use has been extensive as a bone research
tool regarding location and kinetics of bone formation and
growth. This methodology has been utilized to evaluate overall
and site specific bone activity levels around dental implants
in various in-vivo models10,14,27, including dogs and humans.
These studies10,14,27  indicated that the modeling/remodeling
kinetics at regions adjacent to the implant surface (to
approximately 1 mm from surface) may have significant
differences compared to regions away from the surface at
various times in-vivo, and it has been hypothesized15 that
short and long term stability of dental implants are related to
this region of increased bone activity.
The purpose of this investigation was to determine the
overall and site specific (to 0.5 mm from implant surface) levels
of osseoactivity around a thin-film Ca- and P- based
bioceramic coated titanium alloy (Ti-6Al-4V) implant
manufactured by the IBAD process versus a non surface
modified (sand-blasted/acid etched) titanium alloy implant
by means of stereological techniques12 (quantitative
microscopy) in a laboratory dog model.
MATERIALS AND METHODS
Materials
The as-processed, sterilized, and packaged sand-blasted/
acid-etched titanium alloy and thin-film coated titanium alloy
implant rods were provided by the manufacturer (Bicon, Inc.
Boston, MA-USA). These were 10 mm in length by 4 mm in
diameter. The number of devices was 32 and included an
experimental (thin-film bioceramic coated, n=16) and a control
group (sand-blasted/acid-etched, n=16). No detail regarding
surface topography and chemistry was provided by the
manufacturer.
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Methods
Surgical Model and Clinical Aspects
The surgical model comprised 4 mid-size class A adult
(closed bone growth plates) mongrel dogs in good health.
The dogs followed a 2-week housing period before the first
surgical procedure and 4 weeks post-operatively. The project
was conducted after IRB approval in an AALAC approved
facility.
The surgical site was the proximal tibiae epiphyses, with
four implants placed in each limb. Each dog provided a 2- and
4-week comparison between experimental and control surfaces
per four-implant location through sequenced surgical
procedures. The left limb was used for the 4-week evaluation
and the right limb for the 2-week evaluation. The surgeries
were conducted under full anesthesia following sterile
methodologies.
Surgical Site Preparation and Implantation
The proximal tibiae were exposed subperiostally and 4
equi-spaced holes were drilled through sequential burs (under
external saline irrigation). The implants were then inserted
into the trabecular mid-region with its top in contact with the
tibiae proximal cortical plate. A polymeric cover screw was
threaded into the implant top and standard layered procedures
were employed for soft tissue closure. Forty-eight hours prior
to euthanization, 10 mg/kg oxytetracycline was administered
subcutaneously to provide fluorescent labeling for
histomorphometric analyses (single label).
Specimen Preparation
At necropsy, the proximal tibia was exposed by sharp
dissection. The upper one half of the bone was removed and
contact radiographed to confirm implant location and
orientation. The limbs were reduced to blocks with the implant
in its center, which were subsequently processed to thin
sections approximately 20 µm in thickness with the metallic
implant in place through standard procedures for optical light
microscopy.
Hystomorphometric Analyses
General Biocompatibility Evaluation
The nondecalcified specimens were placed under an
optical microscope equipped with an ultra violet source at
20x magnification, and 12 micrographs were acquired around
the implant perimeter. The micrographs were merged by a
computer software (Adobe Photoshop, San Jose, CA- USA),
and the implant perimeter and surrounding bone structure
was obtained for analysis. Qualitative evaluation regarding
biocompatibility was performed for the different groups at
both evaluation times in-vivo.
Tetracycline Labeling Quantification
Quantification of the tetracycline labeled bone area
fraction was performed by acquiring 4 micrographs (40x
magnification) along one side of the implant (total implant
length covered at this magnification). Each of the four
micrographs was subdivided into rectangles (0.5 mm base
and 2.5 mm height) comprising 0.5 mm steps from the implant
surface (Figure 1), and a 9-point grid was randomly placed 6
times for each micrograph subdivision for point-count12
stereologic inferences. This procedure implied 24
tetracycline labeled bone area fraction measurements for
each micrograph and a total of 96 measurements per implant.
The overall quantification of tetracycline labeled bone
area fraction was assessed by considering all measured
quantities for the 4 micrographs and their respective
subdivisions for statistical analysis.
Investigation of the tetracycline labeled bone area
fraction at the site in close proximity to the implant surface
(to 0.5 mm from implant surface) was performed by only
considering  measurements obtained from the subdivision
adjacent to the implant surface for the 4 micrographs
acquired for statistical analysis.
Statistical Analyses
The confidence interval (CI) for each parameter evaluated
through the quantitative microscopy technique described
above was calculated at the 95% level of significance
through the following equations: CI= [mean value ± t
(standard error)], standard error = [standard deviation/(n1/
2)], where t= t value associated with the number of degrees
of freedom and level of significance, and n= number of
observations for the parameter under evaluation12.
FIGURE 1- Representation of a micrograph (at 40x original
magnification) subdivision into 0.5 mm base by 2.5 mm
height rectangles for quantification of tetracycline labeled
bone area fraction
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RESULTS
Surgery and Follow-up
Review and analyses of the surgical procedures and
general immediate follow-up demonstrated no significant
complications regarding procedural conditions and
postoperative infection.
Biocompatibility and Tetracycline Labeling
The merged micrographs revealing the perimeter and
bone structure around a 4-week control implant are shown
in Figure 2. Qualitative evaluation revealed the presence of
bone contact to the implant surface at cortical and trabecular
regions for all specimens, and no evidence (at this
magnification) of the thin-film bioceramic coating on the
surface of experimental groups’ implants was found.
 Tetracycline labels were found for both control and thin-
film coated implants at both times in-vivo, and were present
at regions in proximity and away from the implant surface.
Overall Labeling Quantification
Summary statistics for overall labeling quantification are
presented in Table 1. These results showed that the thin-
film coated implants presented significantly higher values
of tetracycline labeled bone area fraction compared to
control groups at both times in-vivo. Also, the 4-week thin-
film coated group presented significantly higher values of
tetracycline labeled bone area fraction compared to all other
groups. It should be noted that no significant difference
was found between the 2- and 4-week control groups.
Labeling Quantification at Region Adjacent to
Implant Surface (to 0.5 mm from implant
surface)
Tetracycline labeled bone area fraction determination at
the region adjacent to the implant surface (to 0.5 mm from
implant surface) summary statistics are presented in Table
2. The thin-film coated implants presented significantly
higher values of tetracycline labeled bone area fraction at
this particular site compared to control groups at both times
in vivo. Again, the 4-week thin-film coated group presented
significantly higher values of tetracycline labeled bone area
fraction compared to all other groups. No significant
difference was found between the 2- and 4-week control
groups.
DISCUSSION
The results of this study showed that the surgical aspects
of this experiment had no significant negative influences
due to inflammation and/or infection. Specimen loss had no
significant influence in the comparative analyses12 and was
primarily caused by difficulties in nondecalcified specimen
preparation.
Evaluation of the merged micrographs rebuilding the
implant perimeter and surrounding bone architecture showed
that both control and thin-film coated implants are
FIGURE 2- Merged micrographs (20x original magnification)
revealing perimeter and bone structure around a 4-week
titanium alloy (control) implant. Note the presence of
tetracycline labels in both cortical and trabecular bone in
proximity and away from the implant surface. PC- tibiae
proximal cortical plate, DC- tibia distal cortical plate, T-
trabecular bone region
 Group # of   n Mean % A.F. 95% C.I. Std. Std. Coeff. of
   implants Labeled Deviation Error Variance
Control 2 Weeks 7 672 13.56c ±1.06 16.72 0.006 0.048
Control 4 Weeks 7 672 14.22c ±1.07 16.88 0.007 0.046
Experimental 2 Weeks 7 672 24.04b ±1.44 22.62 0.009 0.036
Experimental 4 Weeks 8 768 27.39a ±1.45 24.40 0.009 0.032
TABLE 1- Summary statistics for overall tetracycline bone labeled area fraction quantification for thin-film coated (experimental)
and titanium alloy (control) at 2 and 4 weeks in-vivo
a,b, and c- statistical group CI overlap at 95% level of significance.
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biocompatible and have osseoconductive properties, as per
direct bone-to-implant contact at regions of cortical (proximal
and distal plates) and trabecular bone1-3. This phenomenon
regarded as osseointegration2 is a desirable feature when
considering endosseous dental implants for functional load
bearing applications1-3,5.
The absence of a thin-film bioceramic coating on the
experimental groups’ implants indicated that partial or total
coating dissolution occurred as implantation time elapsed
in-vivo. This feature supports opportunities for direct bone
contact to the underlying metallic substrate of thin-film
coated implants, avoiding the occurrence of weak links
between the bioceramic coating and metallic substrate in-
vivo, where mechanical failure is likely to occur19-20,22. The
partial or total coating dissolution that occurred in-vivo was
possibly related to the low thicknesses thin-film coated
implants and/or its microstructural phase composition15,30.
The presence of fluorescent labels at regions in proximity
and away from the implant surface in all specimens
demonstrated the effectiveness of oxytetracycline as a tissue
marker4,6,13,16,23-24,26, enabling quantification of relative degrees
of bone activity around the implants10,14,27 at both times in-
vivo.
The overall tetracycline labeled area fraction
quantification revealed significantly higher values for the
thin-film coated implants compared to control implants at 2
and 4 weeks in-vivo, demonstrating a significant effect7,21,27
of the surface treatment on bone kinetics, as previously
reported by different methodologies8-9,11,17-18 considering
bioceramic coatings obtained through different processes.
The site specific (to 0.5 mm from implant surface)
tetracycline labeled bone area fraction quantification showed
the same qualitative trends within groups when compared
to the overall tetracycline labeled area fraction quantification,
but presented significant higher values for all groups at
both times in-vivo (no CI overlaps between identical groups
in Tables 1 and 2). These significantly higher values at the
region adjacent to the implant surface indicate that the
modeling/remodeling rates have higher values compared to
regions away from the implant surface, and these values
potentially decrease to physiologic levels as a function of
distance from the implant surface10,14,27.
Alteration in bone kinetics found in both overall and
site specific tetracycline labeled area fraction quantifications
of bone around thin-film coated implants may be beneficial
regarding both potential decreases in osseointegration
time14,20,22,29 (short term stability) and long term implant
stability maintenance14.  It is important to note that no
relationship between increased bone activity and increased
bone-to-implant contact, higher bone-biomaterial interface
mechanical properties, or short- and long-term implant
treatment success ratios have been presented in a concise
manner to date, and both in-vitro, in-vivo, biomechanical,
and controlled clinical research protocols are desirable for
addressing these issues. Protocols involving the full physical
and chemical characterization of the thin-film coating used
throughout this study would also provide valuable insight
on relating bone kinetics to coating characteristics, and may
be subject of future research.
CONCLUSIONS
Bilateral proximal regions of dog tibia were utilized to
study the effect of a thin-film coated (IBAD processed) on
bone activity at times 2 and 4 weeks after implantation, and
according to the stereological (quantitative microscopy)
results obtained, it can be concluded that the Ca- and P-
based bioceramic thin-film (IBAD processed) coated
implants were biocompatible, osseoconductive, and
presented significantly higher overall and site specific (to
0.5 mm distance from implant surface) tetracycline labeled
area fraction values on dog’s bone.
Direct bone contact to the metallic substrate was
achieved for thin-film coated implants while still benefiting
from the surface modification’s effect on bone kinetics at
both times in-vivo, supporting the rationale for thin-film
coatings as candidates to overcome limitations inherent to
commercially available bioceramic coatings processes like
PSHA.
AKNOWLEDGEMENTS
This project was partially funded by Bicon Dental
Implants, Inc. Boston, MA. This study was the first of a
series of histomorphometric, biomechanical, and physico/
chemical characterization investigations concerning IBAD
  n Mean % A.F. 95% C.I. Std. Std. Coeff. of
Labeled Deviation Error Variance
Control 2 Weeks 168 17.79c ±2.41 18.96 1.463 0.082
Control 4 Weeks 168 17.37c ±2.12 16.66 1.285 0.074
Experimental 2 Weeks 168 27.61b ±2.94 23.11 1.783 0.065
Experimental 4 Weeks 192 38.40a ±3.12 26.22 1.892 0.049
TABLE 2- Summary statistics for tetracycline labeled bone area fraction quantification at the region adjacent to the implant
surface (to 0.5 mm) quantification for thin-film coated (experimental) and titanium alloy (control) at 2 and 4 weeks in-vivo
a,b, and c- statistical group CI overlap at 95% level of significance.
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thin-film coatings on dental implants.
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